From the lab to the clinic: Activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic-nerve injury

European Journal of Ophthalmology

Volumn 9, Issue SUPPL. 1, 1999, Pages

  Wheeler, L A ^a   Lai, R ^a   Woldemussie, E ^a  

^a ALLERGAN INC   (United States)

Author keywords

Acute retinal ischemic injury; Alpha 2 adrenoreceptor agonist; Brimonidine; Neuroprotection; Optic nerve injury; Rat crush injury model; TUNEL staining

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRUSH TRAUMA; DRUG EFFECT; GENE INDUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE LESION; PHOTORECEPTOR; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RETINA INJURY; RETINA ISCHEMIA; SIGNAL TRANSDUCTION; VITREOUS BODY;

EID: 0032904676     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219900901s09     Document Type: Article

References (17)

1. Quigley HA, Nickells RW, Kerrigan LA, et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995; 36: 774-86.
2. Okisaka S, Murakami A, Mizukawa A, Ito J. Apoptosis in retinal ganglion cell decrease in human glaucomatous eyes. Jpn J Ophthalmol 1997; 41: 84-8.
3. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human open-angle glaucoma. Arch Ophthalmol 1997; 115: 1031-5.
4. Nickells RW. Retinal ganglior cell death in glaucoma: The how, the why and the maybe. J Glaucoma 1996; 5: 345-56.
5. Vorwerk CK, Lipton SA, Zurakowski D, et al. Chronic low-dose glutamate is toxic to retinal ganglion cells. Invest Ophthalmol Vis Sci 1996; 37: 1618-24.
6. Duvdevani R, Rosner M, Belkin M, Sautter J, Sabel BA, Schwartz M. Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Restor Neurol Neurosci 1990; 2: 31-8.
7. Yoles E, Schwartz M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch Ophthalmol 1998; 116: 906-10.
8. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995; 61: 33-44
9. Yoles E, Wheeler LA, Schwartz M. Alpha-2-adrenoreceptor agonists are neuroprolective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 1999; 40: 65-73.
10. Hicks D, Heidinger V, Mohand-Said S, Sahel J, Dreyfus H. Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ishemia. Gen Pharmacol 1998; 30: 265-73.
11. Sievers J, Hausmann B, Unsicker K, Berry M. Fibroblast growth factors promote the survival or adult rat retinal cells after transection of the optic nerve. Neurosci Lett 1987; 76: 157-62.
12. Peinado-Ramon P, Salvador M, Villegas-Perez MP. Vidal-Sanz M. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells. Invest Ophthalmol Vis Sci 1996; 37: 489-500.
13. Zhang C, Takahasi K, Lam TT, Tso MO. Effects of basic fibroblast growth factor in retinal ischemia. Invest Ophthalmol Vis Sci 1994; 35: 3163-8.
14. Wen R, Cheng T, Li Y, Cao W, Steinberg RH. Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci 1996; 16: 5986-92.
15. Peng M, Yiwen L, Zhijun L, Liu C, Lattes A, Wen R. Alpha-2-adrenergic agonists selectively activate extracellular signal-regulated kinases in Müller cells in vivo. Invest Ophthalmol Vis Sci 1998; 39: 1721-6.
16. Hasson D, Lai RK, Chun T, Wheeler LA. Functional protection of rat retina ischemic injury by brimonidine. Soc Neurosci 1997; 23: 72-4.
17. Chao DT, Korsmeyer SJ. Bcl-2 family: regulators of cell death. Annu Rev Immunol 1998; 16: 395-419.